drug · protein
patient view →cintredekin besudotox
Phase 3updated 2mo agoby Precision Neuromed Inc🔗 ChEMBL
Phase 3community read0 votes
Protein drug with a maximum clinical stage of Phase 3 (across all indications), with 6 investigational indications.
targets
Interleukin 13 receptorInterleukin-13 receptor subunit alpha-2Elongation factor 2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that